Exclusive

Publication

Byline

Lions Club Dehradun holds Seminar on Mental Health

Dehradun, April 13 -- Garhwal Post Bureau Dehradun, 12 Apr: Lions Club Dehradun organised a seminar on mental health and stress management, considering it the need of the hour. It proved to be inform... Read More


'Art has no borders': Pakistan TV channel Geo against notice over Asha Bhosle tribute

India, April 13 -- After Pakistan's electronic media regulator PEMRA issued a show-cause notice to Geo News for airing content related to the death of legendary singer Asha Bhosle, it sparked a broade... Read More


Haryana targeting rRs.r100-cr CSR funding for healthcare upgrade

Chandigarh, April 13 -- In a major push to upgrade public healthcare infrastructure, the Haryana government is targeting Rs.100 crore of Corporate Social Responsibility (CSR) funding this fiscal. Add... Read More


SC seeks ECI, government response on PIL for biometric, facial recognition of voters at polling stations

New Delhi, April 13 -- The Supreme Court on Monday issued notice to the Election Commission of India (ECI), the Centre and states on a PIL seeking direction to implement a finger and Iris biometric id... Read More


Phone row hits IPL: BCCI probes Rajasthan Royals official over dugout breach

India, April 13 -- The Board of Control for Cricket in India (BCCI) has initiated an investigation into a potential anti-corruption protocol breach involving Rajasthan Royals team manager Romi Bhinder... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 13 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 13 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 13 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 13 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, April 13 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More